ANXA2 and acute myeloid leukemia: Other circRNA profiling and bioinformatics studies have also identified hsa_circ_0004277 as a promising AML‐related biomarker,26 and the annexin A2 circRNA has also been highlighted as a promising biomarker and therapeutic in this cancer.27